课题基金 / 基金详情

Generation of a new therapeutic approach against advanced pancreatic cancer by modulating protein tyrosine phosphatases

Generation of a new therapeutic approach against advanced pancreatic cancer by modulating protein tyrosine phosphatases
通过调节蛋白酪氨酸磷酸酶产生针对晚期胰腺癌的新治疗方法
批准号:
341726
负责人:
Tremblay Michel L
金额:
$7.28万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-01-01 至 2017-01-01

项目摘要

项目成果

Tremblay Michel L的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Anti-cancer therapies have multiplied in recent years, notably because of technological and scientific progress in the field of personalized medicine where targeted therapies are being selected based on the genetic profiles of both tumours and patients. A
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
For Improving diagnostics and grasping the disease mechanisms of rare hypomagnesemia in patients with CNNM2 mutations
  • 批准号:
    406731
  • 项目类别:
    Operating Grants
  • 资助金额:
    $16.39万
  • 财政年份:
    2019
  • 负责人:
    Tremblay Michel L
  • 依托单位:
Molecular and physiological understanding of the protein tyrosine phosphatome towards clinical applications.
  • 批准号:
    369211
  • 项目类别:
    Operating Grants
  • 资助金额:
    $219.29万
  • 财政年份:
    2017
  • 负责人:
    Tremblay Michel L
  • 依托单位:
Improving macrophage innate immunity by modulating protein tyrosine phosphatases: the complete mouse and human PTPomes
  • 批准号:
    346783
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2016
  • 负责人:
    Tremblay Michel L
  • 依托单位:
New understanding and targets from the human phosphatome: towards the treatment of castration-resistant prostate cancer.
  • 批准号:
    366581
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2016
  • 负责人:
    Tremblay Michel L
  • 依托单位:
海外基金